Biopreservation Market

Biopreservation Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Product (Biopreservation Media), by Preservation Condition, Type of Serum, Type of Biological Sample, Area of Application, Type of Packaging Format, End Users, and Region

  • Lowest Price Guaranteed From USD 4,799

  • Pages
    197

  • View Count
    10981

I believe that there is a dire need for designing and manufacturing a generic biopreservation media that can be used for the preservation of different types of biological specimen, for shorter as well as longer durations. Companies offering such media are likely to witness lucrative market opportunities in the longer term as well

-- CEO, Europe based small-sized company

Biopreservation Market Overview

The biopreservation market for media is estimated to be worth $800 million in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 23.6% during the forecast period. Over the past few years, there has been an evident growth in the pipeline of cell-based products, fueled by the demand for effective therapeutics. However, such products are often temperature sensitive, requiring freezing / cryogenic conditions for transport and storage. In fact, as per a study conducted by the USFDA, across more than 80% submissions for mesenchymal cell-based therapies, it was reported that such products required cryopreservation. Therefore, there is a need to identify preservation strategies that are capable of potentially protecting the genome and proteome while avoiding stress-related genetic selectivity, which is a condition that most of the current preservation methods fail to meet.

Further, the chosen method should enable speedy restoration to normal physiological function. Specifically, the presence of components, such as animal-derived products, serum and proteins, often acts as a bottleneck for the effective preservation of biological samples. Biopreservation can address a number of product-related concerns by successfully combining engineering concepts with advances in cellular and molecular biology. As a result, there has been a shift in the interest of industry stakeholders towards pre-formulated, commercially available biopreservation media, which have already been checked for their quality, efficacy, safety, post preservation high cell recovery, clinical applicability and cost effectiveness.

At present, over 60 players claim to offer more than 190 biopreservation and biobanking, intended for storage and preservation of different types of biological samples. Recent trends indicate that the biopreservation market is expanding at a rapid rate, as improvements in adjacent disciplines, such as stem-cell research, cell therapy, personalized medicine, cell banking and cancer research, are fueling the need for ameliorated storage techniques for biologics. For instance, Kite Pharma enhanced the stability of its primary oncological product (axacabtagene ciloleucel) from 18 hours to 2 weeks, by transitioning the product to cryopreserved state, easing production limitations and giving logistical flexibility at a lower overall cost. This further provides an opportunity for stakeholders to bring ingenious, improved and relatively economical biopreservation media in the market. It is worth highlighting that the biopreservation and biobanking providers are collaborating with other players in the reparative medicine industry to ensure safe and reliable outcomes. Considering the ever-lasting need for storage and transport of biological samples, as well as supported by the continuous endeavors of the biopreservation media providers to improvise their portfolio, we anticipate an upsurge in the market growth of biopreservation industry during the forecast period.

This image highlights the context of the Biopreservation Media Providers Market report. The rising interest in cell-based therapies, as well as the requirement for optimal cell preservation and post-preservation recovery, has spurred the demand for biopreservation media for preserving biological samples This image provides the list of Biopreservation Media Providers. Globally, over 60 companies provide biopreservation media, intended for the preservation of biological samples at different preservation conditions This image presents the current market landscape of players engaged in Biopreservation Media domain. Biopreservation media is available in different packaging formats that are compatible with a variety of biological samples

Key Companies in Biopreservation Market Developing Media 

Examples of key companies engaged in biopreservation market (which have also been profiled in this market report; the complete list of companies is available in the full report) include BioLife Solutions, Cell Applications, HiMedia Laboratories, Merck, Thermo Fisher Scientific, United States Biological and ZenBio. This report by Roots Analysis on biopreservation industry includes an easily searchable excel database of all the companies providing biopreservation and biobanking, worldwide.

Recent Developments in Biopreservation Market

Several recent developments have taken place in the field of biopreservation industry. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

  • In November 2023, BioLife Solutions announced that it has raised USD 10.4 million through private placement by Casdin Capital to support on-going operations related to biopreservation media and other offerings.
  • In February 2022, OriGen received CE mark approval for the CryoStore™ FLEX Freezing Bag product line. Additionally, the company announced the global launch of CryoStore™ FLEX freezing bag
  • In June 2023, SCTbio collaborated with Cyto-carein in order to improve the quality of cryopreservation for cell therapy development in Europe.

Scope of the Biopreservation Market Report

The “Biopreservation Market by Preservation Condition (Refrigerated, Frozen / Cold Chain, Frozen (Ultra-low) / Deep Frozen, and Cryogenic / LN2 Vapor Phase Storage), Type of Serum (Fetal Bovine Serum Containing Media, Fetal Calf Serum Containing Media, Human Serum Containing Media, and Serum Free Media), Type of Biological Sample (Germline Cells / Stem Cells, Organs, Somatic Cells, and Tissues), Area of Application (Diagnostic Use, Research and Development, and Therapeutic Use), Type of Packaging Format (Bags, Bottles, Vials, and Others), End Users (Academic and Research Institutes, Biobanks / Genebanks, Hospitals, Pharmaceutical and Biotechnology Companies, and Other End Users), and Region (North America, Europe, Asia, MENA, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2021-2035”  market report offers an elaborate study of the current market landscape, market size, market forecast and future opportunities of the biopreservation industry during the forecast period. The market research report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in the domain of biopreservation market.

Amongst other elements, the market report includes:

  • A detailed overview of the current biopreservation media providers’ landscape, including information on the year of establishment, company size, type of company and location of headquarters. In addition, it presents the current market landscape of biopreservation media based on several relevant parameters, such as preservation condition, type of serum, type of biological sample, area of application, type of packaging format, packaging volume and product price.
  • An in-depth analysis of the contemporary market trends, presented using five schematic representations, including [A] a world map representation highlighting the location of headquarters, [B] a 4D bubble chart comparing the leading players engaged in offering biopreservation media based on the parameters, such as year of establishment, company size, number of biopreservation media offered and region, [C] an insightful treemap representation of biopreservation media, distributed on the basis of preservation condition and area of application, [D] a grid representation illustrating the distribution of biopreservation media based on company size, region, preservation condition, type of serum and type of biological sample, and [E] a heat map representation of biopreservation media, distributed on the basis of minimum packaging volume and minimum price.
  • An in-depth company competitiveness analysis of biopreservation media providers, taking into consideration various relevant parameters, such as years of experience, product portfolio strength (in terms of preservation condition, presence of serum, type of biological sample, maximum packaging volume and area of application), and partnership activity (in terms of number of partnerships and type of agreements).
  • Elaborate profiles of various prominent players that are engaged in offering biopreservation media, featuring a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and key members of the executive team), recent developments and an informed future outlook.
  • An analysis of the partnerships that have been inked between various stakeholders in biopreservation market, during the period 2015-2021, covering manufacturing and supply agreements, product distribution agreements, product development agreements, acquisitions and other agreements.
  • A Bowman’s strategy clock framework to understand the pricing strategy of the biopreservation media offered by the company along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the biopreservation media based upon its characteristics.
This image highlights the competitiveness analysis of players providing Biopreservation Media. In order to build a competitive advantage, companies are focused on steadily improving the characteristics of their media offerings This image provides information on the partnership activities of the players engaged in the domain of Biopreservation Media. The growing interest is also evident from the rise in partnership activity; a relatively larger proportion of the deals were signed by companies based in the US This image presents the Bowman’s strategy clock framework to understand the pricing strategy of the biopreservation media. Cost is a key determinant of the acceptance and adoption of such biopreservation media; pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their offerings

One of the key objectives of this market report is to provide a detailed market forecast analysis in order to estimate the existing market size and future opportunity associated with biopreservation market during the forecast period. Based on multiple parameters, such as likely adoption trends, revenues of biopreservation media providers, and expected price variations for these media, we have provided an informed estimate on the evolution of the market for the forecast period 2021-2035.

The market report also features the likely distribution of the current and forecasted opportunity within biopreservation media providers market across

  • Preservation condition (cryogenic / LN2 vapor phase, frozen (ultra-low) / deep frozen, frozen / cold chain, and refrigerated),
  • Type of serum (fetal bovine serum containing media, fetal calf serum containing media, human serum containing media, and serum free media),
  • Type of biological sample (germline cells / stem cells, organs, somatic cells, and tissues), [D] area of application (diagnostic use, research and development, and therapeutic use),
  • Type of packaging format (bags, bottles, vials, and others),
  • Tnd users (academic and research institutes, biobanks / genebanks, hospitals, pharmaceutical and biotechnology companies, and other end users), and
  • Region (North America, Europe, Asia, MENA, Latin America, and Rest of the World).

In order to account for future uncertainties and to add robustness to our forecast model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic scenarios, representing different tracks of the industry’s growth. All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this market research report are in USD, unless otherwise specified.

This image provides information on the current future market trend of the Biopreservation Media domain. Driven by the rising approval of temperature sensitive products, the market for biopreservation media providers is poised to grow at an annualized rate of over 15%, till 2035 This image highlights the market segments of the Biopreservation Media domain. The projected market opportunity is likely to be well distributed across different end users, biological samples, packaging formats and key geographical regions  

Frequently Asked Questions

Question 1: What is biopreservation?

Answer: Biopreservation refers to the process of extending the shelf life of pharmaceutical components using controlled microbes or antimicrobials.

Question 2: How big is the biopreservation market?

Answer: The size of biopreservation industry size for media is estimated to be worth $800 million in 2022.

Question 3: What is the projected market growth of the biopreservation market?

Answer: The biopreservation market for media is expected to grow at compounded annual growth rate (CAGR) of over 23.6% during the forecast period.

Question 4: Which are the leading companies providing biopreservation media in the market?

Answer: Examples of key companies providing biopreservation media in biopreservation market (which have also been profiled in this market report; the complete list of companies is available in the full report) include BioLife Solutions, Cell Applications, HiMedia Laboratories, Merck, Thermo Fisher Scientific, United States Biological and ZenBio.

Question 5: How many companies are currently providing biopreservation media in the biopreservation market?

Answer: Over 60 companies are currently providing biopreservation media in the industry.

Question 6: How many biopreservation media are presently offered by companies engaged in the biopreservation market?

Answer: More than 200 pre-formulated biopreservation media are presently offered by companies engaged in the biopreservation market.

Question 7: Which region is the hub for companies engaged in the biopreservation industry?

Answer: North America emerged as the hub for companies developing biopreservation media, with over 70% of the players established in the region.

PRICING DETAILS

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more about Single-User License

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more about One Location Site License

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more about Department License

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more about Enterprise License

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com